ALPSCAP Berhad

Health is Wealth

Who we are

Alpscap Berhad is a Malaysian leader in providing health and financial solutions to corporations, governments, institutions, families and high nett worth individuals. We strive to put health ahead of wealth.

What we do

We will be your choice partner in investing for the future. We are proud to offer a wide range of products to help you meet your risk management and financial goals. Our products are designed to suit a variety of health and wealth management needs, from long-term growth to steady income to niche investing opportunities.

Health

COVID-19 Protection

We provide post covid-19 treatment to our fervent cliental for rapid recovery.

DNA Sequencing Protection

We provide our clients with a DNA sequencing clinical report upon diagnosed with specific illnesses to gain access to targeted drugs and precision medication.

Cellular Therapy Protection

We provide our clients with the ability to use living cells to treat and fight against critical illnesses

Wealth

Equity or Stock Investment Funds

Our equity or stock funds invest in a diversified portfolio of stocks with the goal of providing long-term growth. We offer a range of options, from broad-based funds that invest in large-cap, mid-cap, or small-cap companies to funds that focus on specific sectors or investment themes.

Bond or Fixed Income Funds

Our bond or fixed income funds invest in a range of fixed income securities, including government bonds, corporate bonds, and other debt instruments. These funds are designed to provide a steady stream of income, making them a great option for investors who are looking for reliable, low-risk returns.

Hybrid or Balanced Funds

Our hybrid or balanced funds invest in a combination of stocks and bonds, offering a balance of growth and income. These funds can be a good option for investors who want exposure to both asset classes but prefer to have a professional manager handle the asset allocation.

Index Funds

Our index funds aim to track the performance of a specific market index, such as the S&P 500 or the Russell 2000. By investing in a portfolio of stocks that closely mirrors the index, these funds offer low-cost, passive exposure to the broader market.

Money Market Funds

Our money market funds invest in highly liquid, low-risk debt securities, providing stability and liquidity. These funds are designed to be a safe place to park cash, while still earning a modest return.

Specialty Funds

Our specialty funds invest in specific sectors or niches, such as real estate, international equities, or commodities. These funds can offer diversification benefits and unique exposure to specific parts of the market.

Target-Date Funds

Our target-date funds are designed for investors who are saving for a specific goal, such as retirement. These funds automatically adjust the investment mix to become more conservative as the target date approaches, helping investors to manage risk as they approach their financial goals.
We also offer a range of financial planning services to help you make the most of your health management and investments, including retirement planning, education savings planning, and portfolio management. Our team of experienced financial professionals is here to help you navigate the markets and make informed decisions.

DR. THAM SENG KONG

CHIEF EXECUTIVE OFFICER (CEO), ALPS GROUP

Facebook Twitter Dribbble Behance

We Care

We strive to lead our team in volunteering service activities benefiting local communities by utilising our many resources and selfless commitment from our employees and family members.

© Copyright 2023 ALPSCAP BERHAD (1275966-K)

DR. THAM SENG KONG

Dr. THAM earned his Bachelor of Medicine from Xiamen University, Doctor of Medicine (MD) Integrated Chinese Medicine & Western Clinical Medicine (Oncology) from Guangzhou University of Chinese Medicine (GUCM) and Doctor of Medicine (PHD) in Biomedical Engineering.

He is involved in ongoing extensive research on anti-aging cellular therapy since 2006. He works very closely with his Swiss and Asian counterparts in advancing the human understanding of cellular therapy and is eager to share his experiences in this field.

He also actively participates in cancer research. One of his important scientific breakthroughs is the discovery of penetrating tyrosinase inhibitor to reduce the production of melanin for skin beauty and whitening. He also described in his recent publication on the successful construction of retroviral transfection system that could be developed as a means of gene therapy for hepatic carcinoma.

Dr. Tham as Group Chief Executive Officer and Group Chief Research Scientist will be the main personality leading and driving the ALPS Group to greater heights towards recognition as a global biotechnology company serving humanity.